Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism kinase inhibitor |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21F3N8 |
InChIKeyZOTNSCLLJKXGSD-UHFFFAOYSA-N |
CAS Registry551919-98-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Staphylococcal Infections | Preclinical | US | 30 Jul 2018 |